Table 1 Baseline characteristics of eligible kidney transplant recipients.

From: A randomized controlled trial of comparative effectiveness between the 2 dose and 3 dose regimens of hepatitis a vaccine in kidney transplant recipients

 

Kidney transplant recipients (n = 401)

Seropositive (n = 285)

Seronegative (n = 116)

p value

Age (years, mean ± SD)

49.9 ± 12.7

54.3 ± 10.9

38.9 ± 9.9

 < 0.001

Male gender (n, (%))

235 (58.6%)

177 (62.1%)

58 (50.0%)

0.026

Type of transplantation (living donors, n (%))

191 (47.6%)

139 (48.7%)

52 (44.8%)

0.473

Time post transplantation (months, mean ± SD)

93.2 ± 66.4

98.9 ± 68.8

78.9 ± 57.7

0.003

Serum creatinine (mg/dL, mean ± SD)

1.48 ± 0.98

1.46 ± 0.83

1.52 ± 1.28

0.588

Back to article page